HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build
Unknown region code '840'
HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions
| Draft as of 2024-08-12 |
{
"resourceType" : "ValueSet",
"id" : "nachc-b2-de103",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet nachc-b2-de103</b></p><a name=\"nachc-b2-de103\"> </a><a name=\"hcnachc-b2-de103\"> </a><a name=\"nachc-b2-de103-en-US\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-hiv-custom.html\"><code>http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE103\">NACHC.B2.DE103</a></td><td>Antinuclear antibodies (ANA)</td><td>Hepatitis C Test - Antinuclear antibodies (ANA)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE104\">NACHC.B2.DE104</a></td><td>Hepatitis C antibody</td><td>Hepatitis C Test - Hepatitis C antibody</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE105\">NACHC.B2.DE105</a></td><td>Hepatitis C antibody; confirmatory test (eg, immunoblot)</td><td>Hepatitis C Test - Hepatitis C antibody; confirmatory test (eg, immunoblot)</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE106\">NACHC.B2.DE106</a></td><td>Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique</td><td>Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE107\">NACHC.B2.DE107</a></td><td>Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed</td><td>Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE108\">NACHC.B2.DE108</a></td><td>Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed</td><td>Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed</td></tr><tr><td><a href=\"CodeSystem-hiv-custom.html#hiv-custom-NACHC.46B2.46DE109\">NACHC.B2.DE109</a></td><td>Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus</td><td>Hepatitis C Test - Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus</td></tr></table></li><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-CPT.html\"><code>http://www.ama-assn.org/go/cpt</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1014274</td><td>Hepatitis C antibody</td></tr></table></li><li>Include these codes as defined in <code>https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>G0472</td><td>Hepatitis c antibody screening, for individual at high risk and other covered indication(s)</td></tr></table></li></ul></div>"
},
"url" : "http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-b2-de103",
"version" : "0.1.0",
"name" : "HepatitisCTestCodes",
"title" : "Hepatitis C Test Codes",
"status" : "draft",
"experimental" : false,
"date" : "2024-08-12T19:50:21+00:00",
"publisher" : "National Association of Community Health Centers, Inc. (NACHC)",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "https://www.nachc.org/"
}
]
}
],
"description" : "Codes representing possible values for the Hepatitis C Test element",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "840"
}
]
}
],
"immutable" : true,
"copyright" : "Copyright National Association of Community Health Centers, Inc. (NACHC)",
"compose" : {
"include" : [
{
"system" : "http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom",
"concept" : [
{
"code" : "NACHC.B2.DE103",
"display" : "Antinuclear antibodies (ANA)"
},
{
"code" : "NACHC.B2.DE104",
"display" : "Hepatitis C antibody"
},
{
"code" : "NACHC.B2.DE105",
"display" : "Hepatitis C antibody; confirmatory test (eg, immunoblot)"
},
{
"code" : "NACHC.B2.DE106",
"display" : "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique"
},
{
"code" : "NACHC.B2.DE107",
"display" : "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed"
},
{
"code" : "NACHC.B2.DE108",
"display" : "Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed"
},
{
"code" : "NACHC.B2.DE109",
"display" : "Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus"
}
]
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"concept" : [
{
"code" : "1014274",
"display" : "Hepatitis C antibody"
}
]
},
{
"system" : "https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets",
"concept" : [
{
"code" : "G0472",
"display" : "Hepatitis c antibody screening, for individual at high risk and other covered indication(s)"
}
]
}
]
}
}
IG © 2021+ National Association of Community Health Centers, Inc. (NACHC). Package fhir.nachc.hiv-cds#0.1.0 based on FHIR 4.0.1. Generated 2024-08-12
Links: Table of Contents |
QA Report
| Version History 
|